Skip to main content

Sana Biotechnology, Inc.

corporate_fare Company Profile

Sana Biotechnology, Inc.

SANA·NASDAQ·Life Sciences·CIK 0001770121

Sana Biotechnology, Inc. develops engineered cells to treat diseases. The company focuses on two main approaches: ex vivo and in vivo cell engineering platforms. Its ex vivo platform utilizes a hypoimmune platform technology, referred to as HIP technology. This technology aims to engineer allogeneic cells that can evade a patient's immune system, preventing rejection and allowing the cells to persist in the body, while also being manufacturable at scale. The company believes this approach can lead to new therapeutics, starting with type 1 diabetes. SC451 is Sana Biotechnology, Inc.'s HIP-edited product candidate for treating type 1 diabetes. For in vivo therapies, the company focuses on cell-specific delivery of genetic payloads, specifically chimeric antigen receptors (CARs), to a patient's T cells. This process generates and proliferates CAR T cells, which are designed to deplete disease-causing B cells. SG293 is Sana Biotechnology, Inc.'s in vivo CAR T product candidate, currently being advanced for the treatment of B cell malignancies and B cell mediated autoimmune diseases. Sana Biotechnology, Inc. aims to address unmet treatment needs across various therapeutic areas, including type 1 diabetes, oncology, and B cell mediated autoimmune diseases.

Sana Biotechnology, Inc. (NASDAQ:SANA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 20 items for SANA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for SANA spans 10-Q, 8-K, 424B5, S-3ASR.

Recent high-impact activity:

  • Sana 10-Q: Going-Concern Warning With $121.7M Cash, Q3 Profit Is Non-Cash
  • Sana Posts $20.4M Q3 Profit on Contingent Consideration Gain, Cash Down to $121.7M
  • Sana's 14-Month UP421 Data Show Durable Islet Survival Without Immunosuppression
  • Sana Biotechnology Warns of Going Concern as Cash Dwindles to ~$160M
  • Sana Biotechnology Q2 2026: $160.5M Cash, Runway into Mid-2027, and Pipeline Momentum

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$244.17M
Diluted EPS
-$0.96
Op. Cash Flow
-$143.83M
Free Cash Flow
-$144.77M
Operating Income
-$250.32M
Cash & Equivalents
$71.87M
Debt / Equity
0.00×
Shares Outstanding
266.73M sh
Source: 10-K · filed 2026-03-03 · accession 0001193125-26-088215

Short Interest & Short Volume

15.77 days to cover

FINRA reported short interest of 40,600,271 shares in SANA as of the October 30, 2026 settlement, a 0.6% decrease from the prior period — about 15.8 days to cover at its recent average daily volume. On November 20, 2026, 60.6% of SANA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)40,600,271 shares as of October 30, 2026
Change vs prior period▼ 0.6%
Days to cover15.77 at avg daily volume of 2,574,377
Daily short volume (FINRA facilities)60.6% of 2,209,583 shares on November 20, 2026
5-day average short volume64.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with S →
$1.64 +3.06% today
52-week range · as of 2026-11-05 $1.64 – $5.49
Market cap
$476.42M
Volume
4.5M (1.5× avg)
3-mo avg 2.9M
Live data · 2026-11-22 07:25 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SANA - Latest Insights

SANA
Nov 05, 2026, 4:11 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.44
Real-time Price: $1.64 info
Change: -$0.8014 (-33%) info
Market Cap: $476.42M info
SANA
Nov 05, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.41
Real-time Price: $1.64 info
Change: -$0.7714 (-32%) info
Market Cap: $476.42M info
SANA
Sep 08, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.85
Real-time Price: $1.64 info
Change: -$2.21 (-57%) info
Market Cap: $476.42M info
SANA
Aug 10, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.53
Real-time Price: $1.64 info
Change: -$1.89 (-54%) info
Market Cap: $476.42M info
SANA
Aug 10, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.53
Real-time Price: $1.64 info
Change: -$1.89 (-54%) info
Market Cap: $476.42M info
SANA
Jul 13, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.73
Real-time Price: $1.64 info
Change: -$2.09 (-56%) info
Market Cap: $476.42M info
SANA
Jun 02, 2026, 6:11 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $3.23
Real-time Price: $1.64 info
Change: -$1.59 (-49%) info
Market Cap: $476.42M info
SANA
May 15, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.07
Real-time Price: $1.64 info
Change: -$1.43 (-47%) info
Market Cap: $476.42M info
SANA
May 15, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.99
Real-time Price: $1.64 info
Change: -$1.35 (-45%) info
Market Cap: $476.42M info
SANA
May 11, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.59
Real-time Price: $1.64 info
Change: -$1.95 (-54%) info
Market Cap: $476.42M info
SANA
May 11, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.60
Real-time Price: $1.64 info
Change: -$1.96 (-54%) info
Market Cap: $476.42M info
SANA
May 11, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $3.59
Real-time Price: $1.64 info
Change: -$1.95 (-54%) info
Market Cap: $476.42M info
SANA
Apr 13, 2026, 5:04 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $3.79
Real-time Price: $1.64 info
Change: -$2.15 (-57%) info
Market Cap: $476.42M info
SANA
Apr 13, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.82
Real-time Price: $1.64 info
Change: -$2.18 (-57%) info
Market Cap: $476.42M info
SANA
Apr 13, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.62
Real-time Price: $1.64 info
Change: -$1.98 (-55%) info
Market Cap: $476.42M info
SANA
Mar 13, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $3.16
Real-time Price: $1.64 info
Change: -$1.52 (-48%) info
Market Cap: $476.42M info
SANA
Mar 03, 2026, 5:20 PM EST
Filing Type: S-3ASR
Importance Score:
7
Price at Filing: $3.98
Real-time Price: $1.64 info
Change: -$2.34 (-59%) info
Market Cap: $476.42M info
SANA
Mar 03, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $3.94
Real-time Price: $1.64 info
Change: -$2.30 (-58%) info
Market Cap: $476.42M info
SANA
Feb 17, 2026, 9:07 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.90
Real-time Price: $1.64 info
Change: -$2.26 (-58%) info
Market Cap: $476.42M info
SANA
Jan 14, 2026, 12:45 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.77
Real-time Price: $1.64 info
Change: -$3.13 (-66%) info
Market Cap: $476.42M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets